You are viewing the site in preview mode

Skip to main content

Advertisement

Table 2 Human chorionic gonadotropin levels (mIU/ml) in patients not treated with MTX (Group 1), treated with MTX by intramuscular injection (Group 2) or treated with MTX by intravenous injection (Group 3)

From: Management of Caesarean scar pregnancy with or without methotrexate before curettage: human chorionic gonadotropin trends and patient outcomes

  Mean ± SD/Rate P value
Group 1(n = 47) Group 2(n = 46) Group 3(n = 14)  
A:Before MTX treatment 44,603.28 ± 38,615.27 25,648.86 ± 16,125.92 0.080
B:After MTX treatment or before curettage 31,163.48 ± 28,626.86 37,712.91 ± 23,880.85 31,005.21 ± 23,029.37 0.196
C:Three days after curettage 2838.68 ± 3.10 4434.98 ± 4.90 3263.46 ± 2.93 0.077
B-A 9664.21 ± 8993.10 22,506.29 ± 36,916.63 0.219
(B-A)/A 0.27 ± 0.213 1.33 ± 3.451 0.273
C/B 0.085 ± 0.04 0.084 ± 0.05 0.79 ± 0.04 0.674